Profiles

Glenn Jacobson

UTAS Home Dr Glenn Jacobson

Glenn Jacobson

Senior Lecturer (Pharmaceutics and Toxicology)

Room 4016, Pharmacy Building, Sandy Bay Campus

+61 3 6226 2202 (phone)

+61 3 6226 2870 (fax)

Glenn.Jacobson@utas.edu.au

Dr Glenn Jacobson is a Senior Lecturer in Pharmaceutics and Toxicology at the School of Medicine. His main research area involves studying the pharmacodynamic and pharmacokinetic aspects of beta2-agonist enantiomers (non-superimposable mirror images called stereoisomers) and their role in both asthma and muscle performance by using technically advanced stereoselective chromatography assays. His sports doping research is internationally funded by the World Anti-Doping Agency.

Career summary

Qualifications

  • PhD, University of Tasmania, Australia, 1996. Thesis: Aspects of the pharmacotherapy of Airways Diseases
  • BPharm(Hons), University of Tasmania, Australia. 1991
  • BPharm, University of Tasmania, Australia. 1990

Biography

Dr Jacobson completed a PhD in pharmacy in 1996 in the area of airways disease pharmacotherapy. Dr Jacobson's research focus is clinical pharmaceutics with a strong emphasis on bio-analytical applications, particularly chiral beta2-agonists, utilising LC-MS/MS. His previous experience includes pharmaceutical industry and commercial laboratory roles in Australia and Europe, undertaking Phase III international clinical trial laboratory data management. Dr Jacobson has undertaken pharmaceutical industry contract research in the area of analytical applications for novel veterinary drug delivery research and 'chiral switch' beta2 agonist food supplementation for animal production both locally and with US collaborators. He has extensive knowledge of analytical techniques, applications, and methodology for assay quality assurance, including familiarity with ICH and FDA guidance documentation (some of Dr Jacobson's work on low molecular weight heparin analysis has been cited by the FDA in guidance documentation and has led to product recalls in North America). Dr Jacobson has leading international expertise in enantioselective analysis of beta2-agonists in a range of tissues with applications to anti-doping research and therapeutics in the area of respiratory medicine, muscle wasting disease and cardiac function. Dr Jacobson has a 40% undergraduate teaching load within the areas of pharmaceutics and toxicology, and is currently supervising four PhD students in projects relating to application of analytical instrumentation in natural products research/drug discovery, and has been primary supervisor for eight RHD completions since 2008.

Research Themes

Dr Jacobson's beta2-agonist research aligns to the University's research theme of Better Health, and lies in the Faculty of Health research theme of Chronic Health. Asthma and Chronic Obstructive Pulmonary Disease (COPD) leads to significant morbidity and mortality in the community. The use of beta2-agonists is a cornerstone of treatment, however, these drugs although very safe and effective if used appropriately, have been associated with worsening asthma control and some paradoxical deaths. There are some concerns that part of the problem may be due to the medications being used as racemic mixtures of stereoisomers, where one isomer is pharmacologically active, and the other may actually lead to increased bronchial hyper-responsiveness. It is not known if there are differences in the bronchopulmonary pharmacokinetics (time course of drug in the lung) between enantiomers, and whether this may lead to worsening bronchodilatory function in some individuals with asthma or COPD. It is also unclear if genetics is a determinant of differences in uptake and metabolism between patients.

Administrative expertise

Dr Jacobson has experience in GCP compliance and has current GCP certification, with particularly expertise in clinical data management, CRF design, GLP and bio-analytical procedure validation.  Dr Jacobson has a 20% administrative load consisting of unit administration for second and third year pharmaceutics and toxicology, and is currently second year coordinator of the BPharm program. Dr Jacobson has previously held the position of Deputy Head of School (Pharmacy) 2009-11, and non-professorial elected member for Academic Senate (2010-11). He also sits on the Central Science Laboratory Users Group (2008-) and is a member of the Tasmania Health and Medical Human Research Ethics Committee (IRB) (2015-).

Teaching

toxicology, clinical toxicology, pharmaceutics, drug delivery, drug discovery, drug stability, drug analysis, enantiomer, chiral.

Teaching expertise

Dr Jacobson has particular teaching expertise in the drug sciences, namely pharmaceutics (the science of drug delivery which focuses on physicochemical properties of drugs and their delivery systems and how these properties relate to effectively getting a drug to the site of action in the body) and clinical toxicology. He has developed and taught the current pharmaceutical science and toxicology units, in line with current BPharm professional competency standards. Dr Jacobson has previously co-developed a Masters coursework program (MPharmSc) within the Division of Pharmacy, and was previously coordinator for the BPharm(Hons) program where he developed Honours assessment rubrics.

Teaching responsibility

View more on Dr Glenn Jacobson in WARP

Expertise

Dr Jacobson's research focus is clinical pharmaceutics with a strong emphasis on bio-analytical applications, particularly chiral beta2-agonists, utilising LC-MS/MS. His previous experience includes pharmaceutical industry and commercial laboratory roles in Australia and Europe, undertaking Phase III international clinical trial laboratory data management. Dr Jacobson has undertaken pharmaceutical industry contract research in the area of analytical applications for novel veterinary drug delivery research and 'chiral switch' beta2 agonist food supplementation for animal production both locally and with US collaborators. He has extensive knowledge of analytical techniques, applications, and methodology for assay quality assurance, including familiarity with ICH and FDA guidance documentation (some of Dr Jacobson's work on low molecular weight heparin analysis has been cited by the FDA in guidance documentation and has led to product recalls in North America). He has undertaken industry consultancies involved with the chemical characterisation and synthesis of previously unidentified impurities in pharmaceutical products for regulatory compliance. Dr Jacobson has leading international expertise in enantioselective analysis of beta2-agonists in a range of tissues with applications to anti-doping research and therapeutics in the area of muscle wasting disease and cardiac function.

Awards

  •  University of Tasmania, Business Competition Grant (2008) for commercialisation of research

Collaboration

Dr Jacobson is a member of the 'Breathe Well' CRE and has local collaborations within the Menzies Institute for Medical Research (Blood Pressure Research Group and the Muscle Metabolism Group), with work in the area of asthma, COPD and smoking studies related to beta2-agonists, as well as genetic determinants of Phase 1 and Phase 2 metabolism and flavonoid effects on muscle. He also collaborates with research groups at the Sackler Institute (Kings College, UK), University of Otago (NZ), and University of Copenhagen with regard to enantioselective beta2-agonist analyses and applications in respiratory and doping research. Dr Jacobson is currently involved in development of novel bronchopulmonary sampling techniques to measure enantioselective deposition and uptake in a horse model with collaborators in the School of Animal and Veterinary Sciences at Charles Sturt University, along with other chiral veterinary drug projects.

Current projects

  • Enantioselective pharmacokinetics of salbutamol and application to doping control
  • Effect of oral and inhaled salbutamol on muscle performance, exhaled gases, cardiac physiology using pulse wave analysis, and airway flow volume
  • Enantioselective pharmacokinetics of formoterol and application to doping control
  • Effect of oral and inhaled formoterol on muscle performance, exhaled gases, cardiac physiology using pulse wave analysis, and airway flow volume
  • Assay development and enantioselective pharmacokinetics of formoterol in urine.
  • Enantioselective pharmacokinetics of salmeterol in urine
  • Enantioselective bronchopulmonary pharmacokinetics of salbutamol in a horse model using direct epithelial lining fluid (ELF) over time via direct swab sampling, central and peripheral lung tissue (via endoscopic bronchial biopsy and percutaneous pulmonary biopsy respectively)
  • Relationship between cardiac markers and salbutamol plasma levels in COPD patients.
  • Enantioselective pharmacodynamic/pharmacokinetic relationship for the alpha2-agonist medetomidine in dog pre-anaesthesia
  • Development of a zebrafish pericardial oedema model and measurement of cardiac physiology
  • Characterisation and biological effect of novel flavonoids on microvascular uptake and blood glucose

Research Fields

  • Pharmaceutical Sciences (111504)
  • Pharmacology and Pharmaceutical Sciences (111599)
  • Clinical Pharmacology and Therapeutics (111502)
  • Epidemiology (111706)
  • Basic Pharmacology (111501)
  • Cardiology (incl. Cardiovascular Diseases) (110201)
  • Preventive Medicine (111716)
  • Public Health and Health Services (111799)
  • Toxicology (incl. Clinical Toxicology) (111506)
  • Respiratory Diseases (110203)
  • Primary Health Care (111717)
  • Animal Protection (Pests and Pathogens) (070205)
  • Veterinary Pharmacology (070710)
  • Animal Growth and Development (070202)
  • Anaesthesiology (110301)
  • Neurosciences (110999)
  • Gene Expression (incl. Microarray and other genome-wide approaches) (060405)
  • Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics) (110106)
  • Paediatrics (111403)
  • Biologically Active Molecules (030401)
  • Nutrition and Dietetics (111199)
  • Separation Science (030108)
  • Medical Biochemistry: Carbohydrates (110102)
  • Technology (109999)
  • Podiatry (110318)
  • Traditional Aboriginal and Torres Strait Islander Medicine and Treatments (110403)
  • Instrumental Methods (excl. Immunological and Bioassay Methods) (030105)
  • Medical Infection Agents (incl. Prions) (110802)
  • Veterinary Parasitology (070708)
  • Agronomy (070302)
  • Plant Physiology (060705)
  • Gastroenterology and Hepatology (110307)
  • Medicinal and Biomolecular Chemistry (030499)
  • Oncology and Carcinogenesis (111299)
  • Medical Microbiology (110899)
  • Sports Medicine (110604)
  • Infectious Diseases (110309)
  • Dermatology (110304)
  • Analytical Chemistry (030199)
  • Medical Biochemistry and Metabolomics (110199)
  • Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (111204)
  • Clinical Pharmacy and Pharmacy Practice (111503)
  • Proteomics and Intermolecular Interactions (excl. Medical Proteomics) (060109)
  • Nutritional Physiology (111103)
  • Rheumatology and Arthritis (110322)
  • Tumour Immunology (110709)
  • Exploration Geochemistry (040201)
  • Systems Physiology (111603)
  • Pathology (110316)
  • Agricultural Land Management (070101)
  • Cell Physiology (111601)
  • Orthopaedics (110314)
  • Crop and Pasture Biomass and Bioproducts (070304)
  • Dental Therapeutics, Pharmacology and Toxicology (110502)
  • Analytical Spectrometry (030101)
  • Environmental and Occupational Health and Safety (111705)
  • Medical Biotechnology (100499)
  • Veterinary Medicine (070706)
  • Agricultural Biotechnology Diagnostics (incl. Biosensors) (100101)
  • Crop and Pasture Production (070399)
  • Organometallic Chemistry (039904)
  • Veterinary Microbiology (excl. Virology) (070707)
  • Neurology and Neuromuscular Diseases (110904)
  • Pharmacogenomics (111505)
  • Cancer Cell Biology (111201)
  • Crop and Pasture Improvement (Selection and Breeding) (070305)
  • Genetics (060499)
  • Biochemistry and Cell Biology (060199)
  • Complementary and Alternative Medicine (110499)
  • Human Movement and Sports Science (110699)
  • Health Promotion (111712)

Research Impact

  • Health (929999)
  • Respiratory System and Diseases (incl. Asthma) (920115)
  • Skeletal System and Disorders (incl. Arthritis) (920116)
  • Cardiovascular System and Diseases (920103)
  • Skin and Related Disorders (920117)
  • Diagnostic Methods (920203)
  • Infectious Diseases (920109)
  • Preventive Medicine (920412)
  • Health Related to Ageing (920502)
  • Beef Cattle (830301)
  • Cancer and Related Disorders (920102)
  • Diabetes (920104)
  • Fisheries - Aquaculture (830199)
  • Environmental Health (920405)
  • Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
  • Plant Production and Plant Primary Products (829999)
  • Neurodegenerative Disorders Related to Ageing (920112)
  • Public Health (excl. Specific Population Health) (920499)
  • Blood Disorders (920101)
  • Digestive System Disorders (920105)
  • Substance Abuse (920414)
  • Allied Health Therapies (excl. Mental Health Services) (920201)
  • Nervous System and Disorders (920111)
  • Health Status (e.g. Indicators of Well-Being) (920408)
  • Nutrition (920411)
  • Deer (830303)
  • Environmentally Sustainable Plant Production (829899)
  • Urogenital System and Disorders (920119)
  • Veterinary Biological Preventatives (e.g. Vaccines) (860901)
  • Health and Support Services (920299)
  • Expanding Knowledge in Technology (970110)
  • Expanding Knowledge in the Biological Sciences (970106)
  • Human Pharmaceutical Products (860899)
  • Pasture, Browse and Fodder Crops (830499)
  • Poultry (830309)
  • Child Health (920501)
  • Fresh Fruit and Vegetables (Post Harvest) (820602)
  • Pigs (830308)
  • Rural Health (920506)
  • Mineral Exploration (840199)
  • Sugar Cane (Cut for Crushing) (820603)
  • Evaluation of Health Outcomes (920204)
  • Hearing, Vision, Speech and Their Disorders (920107)
  • Plastic Products (incl. Construction Materials) (860607)
  • Social Structure and Health (920413)
  • Scientific Instruments (861503)
  • Vegetables (820215)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Surgical Methods and Procedures (920118)
  • Human Diagnostics (860802)
  • Health Education and Promotion (920205)

Publications

Dr Jacobson has been working in the area of stereoselective analyses of beta2-agonists since 2003, with accelerated impact in this area over the last 5 years made possible due to generational advances in UPLC-MS/MS instrumentation. Dr Jacobson's work includes the first studies demonstrating stereoselective uptake of salbutamol into tissue. To-date, this work has resulted in over 350 non-self-citations with an h-index of 10.

Total publications

113

Highlighted publications

(7 outputs)
YearTypeCitationAltmetrics
2016Journal ArticleJacobson GA, Fawcett JP, 'Beta2-Agonist Doping Control and Optical Isomer Challenges', Sports Medicine: Reviews of Applied Medicine and Science in Sport and Exercise ISSN 0112-1642 (2016) [Refereed Article]

DOI: 10.1007/s40279-016-0547-4 [eCite] [Details]

Tweet

2014Journal ArticleJacobson GA, Ferguson SG, 'Relationship between cotinine and trans-3' -hydroxycotinine glucuronidation and the nicotine metabolite ratio in Caucasian smokers', Biomarkers pp. 1-5. ISSN 1366-5804 (2014) [Refereed Article]

DOI: 10.3109/1354750X.2014.966254 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Ferguson SG

Tweet

2014Journal ArticleJacobson GA, Yee KC, Wood-Baker R, Walters EH, 'SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: Are some athletes at risk of higher urine levels?', Drug testing and analysis Article 1645. ISSN 1942-7611 (2014) [Refereed Article]

DOI: 10.1002/dta.1645 [eCite] [Details]

Co-authors: Yee KC; Wood-Baker R; Walters EH

Tweet

2014Journal ArticlePirie AD, Davies NW, Ahuja KDK, Adams MJ, Shing CM, et al., 'Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats', Food and Chemical Toxicology, 66 pp. 134-139. ISSN 0278-6915 (2014) [Refereed Article]

DOI: 10.1016/j.fct.2014.01.034 [eCite] [Details]

Co-authors: Pirie AD; Davies NW; Ahuja KDK; Adams MJ; Shing CM; Narkowicz C; Geraghty DP

Tweet

2013Journal ArticleJacobson GA, Yee KC, Premilovac D, Rattigan S, 'Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle', Drug Testing and Analysis pp. 1-5. ISSN 1942-7611 (2013) [Refereed Article]

DOI: 10.1002/dta.1575 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Yee KC; Premilovac D; Rattigan S

Tweet

2011Journal ArticleYee KC, Lowe E, Jacobson GA, 'Determination of Albuterol Enantiomers in Animal Tissue Matrices by LC-MS/MS: Application in Therapeutic Myoanabolic Studies', Chromatographia, 74, (3-4) pp. 355-358. ISSN 0009-5893 (2011) [Refereed Article]

DOI: 10.1007/s10337-011-2061-z [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Yee KC; Lowe E

Tweet

2008Journal ArticlePatel R, Narkowicz CK, Hutchinson J, Hilder EF, Jacobson GA, 'A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins', Journal of Pharmaceutical and Biomedical Analysis, 46, (1) pp. 30-35. ISSN 0731-7085 (2008) [Refereed Article]

DOI: 10.1016/j.jpba.2007.10.009 [eCite] [Details]

Citations: Scopus - 52Web of Science - 44

Co-authors: Patel R; Narkowicz CK; Hutchinson J; Hilder EF

Tweet

Journal Article

(53 outputs)
YearCitationAltmetrics
2016Cui H, King AE, Jacobson GA, Small DH, 'Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice', Journal of Neuroscience Research pp. 1-8. ISSN 0360-4012 (2016) [Refereed Article]

DOI: 10.1002/jnr.23880 [eCite] [Details]

Co-authors: Cui H; King AE; Small DH

Tweet

2016Edwards SH, Khalfan S, Jacobson GA, Pirie A, Raidal SL, 'Pharmacokinetics of intravenous continuous rate infusions of sodium benzylpenicillin 2 and ceftiofur sodium in adult horses', American Journal of Veterinary Research ISSN 0002-9645 (In Press) [Refereed Article]

[eCite] [Details]

Co-authors: Pirie A

2016Jacobson GA, Hostrup M, 'Terbutaline: level the playing field for inhaled β2-agonists by introducing a dosing and urine threshold', British Journal of Sports Medicine ISSN 0306-3674 (2016) [Refereed Article]

DOI: 10.1136/bjsports-2016-096453 [eCite] [Details]

Tweet

2016Jacobson GA, Fawcett JP, 'Beta2-Agonist Doping Control and Optical Isomer Challenges', Sports Medicine: Reviews of Applied Medicine and Science in Sport and Exercise ISSN 0112-1642 (2016) [Refereed Article]

DOI: 10.1007/s40279-016-0547-4 [eCite] [Details]

Tweet

2015Obaid NA, Jacobson GA, Tristram S, 'Relationship between clinical site of isolation and ability to form biofilms in vitro in nontypeable Haemophilus influenzae', Canadian Journal of Microbiology, 61, (3) pp. 243-245. ISSN 0008-4166 (2015) [Refereed Article]

DOI: 10.1139/cjm-2014-0763 [eCite] [Details]

Co-authors: Tristram S

Tweet

2015Lu W, Ferguson SG, Nichols D, Patel R, Jacobson GA, 'Determination of nicotine in cartridge-based electronic cigarettes', Analytical Letters, 48, (17) pp. 2715-2722. ISSN 0003-2719 (2015) [Refereed Article]

DOI: 10.1080/00032719.2015.1048349 [eCite] [Details]

Co-authors: Lu W; Ferguson SG; Nichols D; Patel R

Tweet

2015Thomas J, Narkowicz CK, Jacobson GA, Peterson GM, 'Safety and efficacy of kunzea oil-containing formulations for the management of psoriasis: A randomized, controlled trial', Journal of Clinical Pharmacy and Therapeutics, 40, (5) pp. 566-572. ISSN 0269-4727 (2015) [Refereed Article]

DOI: 10.1111/jcpt.12311 [eCite] [Details]

Co-authors: Narkowicz CK; Peterson GM

Tweet

2014Chhetri J, Jacobson G, Gueven N, 'Zebrafish - on the move towards ophthalmological research', Eye, 28 pp. 367-380. ISSN 0950-222X (2014) [Refereed Article]

DOI: 10.1038/eye.2014.19 [eCite] [Details]

Citations: Scopus - 11

Co-authors: Chhetri J; Gueven N

Tweet

2014Jacobson GA, Ferguson SG, 'Relationship between cotinine and trans-3' -hydroxycotinine glucuronidation and the nicotine metabolite ratio in Caucasian smokers', Biomarkers pp. 1-5. ISSN 1366-5804 (2014) [Refereed Article]

DOI: 10.3109/1354750X.2014.966254 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Ferguson SG

Tweet

2014Jacobson GA, Pirie A, Edwards S, Hughes KJ, Rendle DI, et al., 'Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications', Journal of Pharmaceutical and Biomedical Analysis, 94 pp. 54-57. ISSN 0731-7085 (2014) [Refereed Article]

DOI: 10.1016/j.jpba.2014.01.016 [eCite] [Details]

Citations: Scopus - 4Web of Science - 5

Co-authors: Pirie A; Davies NW

Tweet

2014Jacobson GA, Yee KC, Wood-Baker R, Walters EH, 'SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: Are some athletes at risk of higher urine levels?', Drug testing and analysis Article 1645. ISSN 1942-7611 (2014) [Refereed Article]

DOI: 10.1002/dta.1645 [eCite] [Details]

Co-authors: Yee KC; Wood-Baker R; Walters EH

Tweet

2014Pirie AD, Davies NW, Ahuja KDK, Adams MJ, Shing CM, et al., 'Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats', Food and Chemical Toxicology, 66 pp. 134-139. ISSN 0278-6915 (2014) [Refereed Article]

DOI: 10.1016/j.fct.2014.01.034 [eCite] [Details]

Co-authors: Pirie AD; Davies NW; Ahuja KDK; Adams MJ; Shing CM; Narkowicz C; Geraghty DP

Tweet

2014Shastri M, Lu W, Ferguson SG, Narkowicz CK, Davies NW, et al., 'Determination of cotinine, 3'-hydroxycotinine, and their glucuronides in urine by ultra-high performance liquid chromatography', Analytical Letters, 48, (8) pp. 1217-1233. ISSN 0003-2719 (2014) [Refereed Article]

DOI: 10.1080/00032719.2014.979363 [eCite] [Details]

Citations: Scopus - 1Web of Science - 2

Co-authors: Shastri M; Lu W; Ferguson SG; Narkowicz CK; Davies NW

Tweet

2013Jacobson GA, Yee KC, Premilovac D, Rattigan S, 'Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle', Drug Testing and Analysis pp. 1-5. ISSN 1942-7611 (2013) [Refereed Article]

DOI: 10.1002/dta.1575 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Yee KC; Premilovac D; Rattigan S

Tweet

2013Cui H, Freeman C, Jacobson GA, Small DH, 'Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's disease', IUBMB Life, 65, (2) pp. 108-120. ISSN 1521-6543 (2013) [Refereed Article]

DOI: 10.1002/iub.1118 [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Co-authors: Cui H; Small DH

Tweet

2013Pirie A, Parsons D, Renggli J, Narkowicz C, Jacobson GA, et al., 'Modulation of flavonoid and tannin production of Carpobrotus rossii by environmental conditions', Environmental and Experimental Botany, 87 pp. 19-31. ISSN 0098-8472 (2013) [Refereed Article]

DOI: 10.1016/j.envexpbot.2012.10.001 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Pirie A; Parsons D; Narkowicz C; Shabala S

Tweet

2013Jin F, Narkowicz C, Jacobson GA, 'Protoanemonin content variation between Clematis spp.: Leaf, Stem and Root', Natural Product Communications, 8, (2) pp. 211-212. ISSN 1934-578X (2013) [Refereed Article]

[eCite] [Details]

Citations: Scopus - 1

Co-authors: Narkowicz C

2012Cui H, Hung AC, Freeman C, Narkowicz C, Jacobson GA, et al., 'Size and sulfation are critical for the effect of heparin on APP processing and A beta production', Journal of Neurochemistry, 123, (3) pp. 447-457. ISSN 0022-3042 (2012) [Refereed Article]

DOI: 10.1111/j.1471-4159.2012.07929.x [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Cui H; Hung AC; Narkowicz C; Small DH

Tweet

2012Jacobson GA, Ives SJ, Narkowicz C, Jones G, 'Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study', Clinical Rheumatology, 31, (11) pp. 1543-1547. ISSN 0770-3198 (2012) [Refereed Article]

DOI: 10.1007/s10067-012-2046-9 [eCite] [Details]

Citations: Scopus - 4Web of Science - 5

Co-authors: Ives SJ; Narkowicz C; Jones G

Tweet

2011Cui H, Hung AC, Klaver DW, Suzuki T, Freeman C, et al., 'Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice', PLoS One, 6, (7) Article e23007. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0023007 [eCite] [Details]

Citations: Scopus - 10Web of Science - 5

Co-authors: Cui H; Hung AC; Klaver DW; Narkowicz C; Small DH

Tweet

2011Geraghty DP, Ahuja KDK, Pittaway J, Shing C, Jacobson GA, et al., 'In vitro antioxidant, antiplatelet and anti-inflammatory activity of Carpobrotus rossii (pigface) extract', Journal of Ethnopharmacology, 134, (1) pp. 97-103. ISSN 0378-8741 (2011) [Refereed Article]

DOI: 10.1016/j.jep.2010.11.060 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Geraghty DP; Ahuja KDK; Pittaway J; Shing C; Jager N; Jurkovic S; Narkowicz C; Saunders CI; Ball M; Pinkard A; Adams MJ

Tweet

2011Pirie A, Shabala S, Parsons D, Narkowicz C, Jacobson G, et al., 'Ecophysiology of Carpobrotus rossii in Tasmania: Linking plant's antioxidant activity with a natural habitat', Ecological Questions , 14 pp. 91-93. ISSN 1644-7298 (2011) [Refereed Article]

[eCite] [Details]

Co-authors: Pirie A; Shabala S; Parsons D; Narkowicz C

2011Yee KC, Jacobson GA, Wood-Baker R, Walters EH, 'Albuterol enantiomer levels, lung function and QTc interval in patients with acute severe asthma and COPD in the emergency department', International Journal of Emergency Medicine (Online) , 4, (1) Article 30. ISSN 1865-1380 (2011) [Refereed Article]

DOI: 10.1186/1865-1380-4-30 [eCite] [Details]

Citations: Scopus - 4

Co-authors: Yee KC; Wood-Baker R; Walters EH

Tweet

2011Yee KC, Lowe E, Jacobson GA, 'Determination of Albuterol Enantiomers in Animal Tissue Matrices by LC-MS/MS: Application in Therapeutic Myoanabolic Studies', Chromatographia, 74, (3-4) pp. 355-358. ISSN 0009-5893 (2011) [Refereed Article]

DOI: 10.1007/s10337-011-2061-z [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Yee KC; Lowe E

Tweet

2010Blair C, Walls J, Davies NW, Jacobson GA, 'Volatile organic compounds in runners near a roadway: increased blood levels after short-duration exercise', British Journal of Sports Medicine, 44, (10) pp. 731-735. ISSN 0306-3674 (2010) [Refereed Article]

DOI: 10.1136/bjsm.2008.051888 [eCite] [Details]

Co-authors: Blair C; Walls J; Davies NW

Tweet

2010Thomas J, Narkowicz CK, Jacobson GA, Davies NW, 'An examination of the essential oils of Tasmanian Kunzea ambigua, other Kunzea spp. and commercial kunzea oil', Journal of Essential Oil Research, 22, (5) pp. 381-385. ISSN 1041-2905 (2010) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 1

Co-authors: Thomas J; Narkowicz CK; Davies NW

2010Thomas Jackson, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, et al., 'Toenail onychomycosis: an important global disease burden', Journal of Clinical Pharmacy and Therapeutics, 35, (5) pp. 497-519. ISSN 0269-4727 (2010) [Refereed Article]

DOI: 10.1111/j.1365-2710.2009.01107.x [eCite] [Details]

Citations: Scopus - 85Web of Science - 70

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM

Tweet

2009Patel R, Narkowicz CK, Jacobson GA, 'Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin', Journal of Pharmaceutical Science, 98, (5) pp. 1700 - 1711. ISSN 0022-3549 (2009) [Refereed Article]

DOI: 10.1002/jps.21556 [eCite] [Details]

Citations: Scopus - 9Web of Science - 8

Co-authors: Patel R; Narkowicz CK

Tweet

2009Patel R, Narkowicz CK, Jacobson GA, 'Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution', Journal of Pharmaceutical Science, 98, (3) pp. 1118 - 1128. ISSN 0022-3549 (2009) [Refereed Article]

DOI: 10.1002/jps.21483 [eCite] [Details]

Citations: Scopus - 7Web of Science - 8

Co-authors: Patel R; Narkowicz CK

Tweet

2009Thomas J, Narkowicz C, Peterson GM, Jacobson GA, Narayana A, 'Randomised controlled trial of the treatment of pastern dermatitis with a formulation containing kunzea oil', Veterinary Record, 164, (20) pp. 619-623. ISSN 0042-4900 (2009) [Refereed Article]

DOI: 10.1136/vr.164.20.619 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Thomas J; Narkowicz C; Peterson GM; Narayana A

Tweet

2009Thomas Jackson, Webb CE, Narkowicz CK, Jacobson GA, Peterson GM, et al., 'Evaluation of repellent properties of volatile extracts from the Australian native plant Kunzea ambigua against Aedes aegypti (Diptera: Culcidae)', Journal of Medical Entomology, 46, (6) pp. 1387-1391. ISSN 0022-2585 (2009) [Refereed Article]

DOI: 10.1603/033.046.0619 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM; Davies NW

Tweet

2009Patel R, Narkowicz CK, Jacobson GA, 'Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins ', Analytical Biochemistry, 387, (1) pp. 113-121. ISSN 0003-2697 (2009) [Refereed Article]

DOI: 10.1016/j.ab.2009.01.007 [eCite] [Details]

Citations: Scopus - 21Web of Science - 21

Co-authors: Patel R; Narkowicz CK

Tweet

2008Patel R, Narkowicz CK, Jacobson GA, 'In vitro stability of enoxaparin solutions (20 mg/mL) diluted in 4% glucose', Clinical Therapeutics, 30, (10) pp. 1880-1885. ISSN 0149-2918 (2008) [Refereed Article]

DOI: 10.1016/j.clinthera.2008.10.014 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Patel R; Narkowicz CK

Tweet

2008Patel R, Narkowicz CK, Hutchinson J, Hilder EF, Jacobson GA, 'A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins', Journal of Pharmaceutical and Biomedical Analysis, 46, (1) pp. 30-35. ISSN 0731-7085 (2008) [Refereed Article]

DOI: 10.1016/j.jpba.2007.10.009 [eCite] [Details]

Citations: Scopus - 52Web of Science - 44

Co-authors: Patel R; Narkowicz CK; Hutchinson J; Hilder EF

Tweet

2007Jacobson GA, Tong YC, Townsend AT, Featherstone AM, Ball MJ, et al., 'Selenium status in Southern Tasmania', European Journal of Clinical Nutrition, 61, (9) pp. 1057-1063. ISSN 0954-3007 (2007) [Refereed Article]

DOI: 10.1038/sj.ejcn.1602628 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Tong YC; Townsend AT; Featherstone AM; Ball MJ; Robertson IK; Peterson GM

Tweet

2007Jacobson GA, Yee K, Ng CH, 'Elevated plasma glutathione peroxidase concentration in acute severe asthma: Comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde', Scandinavian Journal of Clinical and Laboratory Investigation, 67, (4) pp. 423-430. ISSN 0036-5513 (2007) [Refereed Article]

DOI: 10.1080/00365510601153353 [eCite] [Details]

Citations: Scopus - 11Web of Science - 9

Co-authors: Yee K

Tweet

2007Jacobson GA, Narkowicz CK, Lord RJ, Howard B-J, Chung S, 'Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus', Diseases of the Esophagus, 20, (3) pp. 265-268. ISSN 1120-8694 (2007) [Refereed Article]

DOI: 10.1111/j.1442-2050.2007.00684.x [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Narkowicz CK; Lord RJ

Tweet

2006Cunningham CP, Brown JM, Jacobson GA, Brandon MR, Martinod SR, 'Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs', American Journal of Veterinary Research, 67, (9) pp. 1564-1569. ISSN 0002-9645 (2006) [Refereed Article]

DOI: 10.2460/ajvr.67.9.1564 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2006Jacobson GA, Martinod S, Cunningham CP, 'Determination of ceftiofur in bovine plasma by HPLC-DAD', Journal of Pharmaceutical and Biomedical Analysis, 40, (5) pp. 1249-1252. ISSN 0731-7085 (2006) [Refereed Article]

DOI: 10.1016/j.jpba.2005.09.010 [eCite] [Details]

Citations: Scopus - 14Web of Science - 14

Tweet

2006Jacobson GA, Narkowicz CK, Tong YC, Peterson GM, 'Plasma glutathione peroxidase by ELISA and relationship to selenium level', Clinica Chimica Acta, 369, (1) pp. 100-103. ISSN 0009-8981 (2006) [Refereed Article]

DOI: 10.1016/j.cca.2006.01.007 [eCite] [Details]

Citations: Scopus - 18Web of Science - 16

Co-authors: Narkowicz CK; Tong YC; Peterson GM

Tweet

2005Jacobson GA, Featherstone AM, Townsend AT, Lord RJ, Peterson GM, 'Selenoprotein P analysis in human plasma - A discrepancy between HPLC fractionation of human plasma with heparin-affinity chromatography and SDS-PAGE with immunoblot analysis', Biological Trace Element Research, 107, (3) pp. 213-220. ISSN 0163-4984 (2005) [Refereed Article]

DOI: 10.1385/BTER:107:3:213 [eCite] [Details]

Citations: Scopus - 7Web of Science - 6

Co-authors: Featherstone AM; Townsend AT; Lord RJ; Peterson GM

Tweet

2005Pourmokhtar M, Jacobson GA, 'Enhanced stability of sulfamethoxazole and trimethoprim against oxidation using hydroxypropyl-B-cyclodextrin', Pharmazie, 60, (11) pp. 837-839. ISSN 0031-7144 (2005) [Refereed Article]

[eCite] [Details]

Citations: Scopus - 9Web of Science - 7

Co-authors: Pourmokhtar M

2004Featherstone AM, Townsend AT, Jacobson GA, Peterson GM, 'Comparison of methods for the determination of total selenium in plasma by magnetic sector inductively coupled plasma mass spectrometry', Analytica Chimica Acta, 512, (2) pp. 319-327. ISSN 0003-2670 (2004) [Refereed Article]

DOI: 10.1016/j.aca.2004.02.058 [eCite] [Details]

Citations: Scopus - 28Web of Science - 25

Co-authors: Featherstone AM; Townsend AT; Peterson GM

Tweet

2004Townsend AT, Featherstone AM, Chery CC, Vanhaecke F, Kirby J, et al., 'Increased selenium concentrations in seronorm trace elements serum', Clinical Chemistry, 50, (8) pp. 1481. ISSN 0009-9147 (2004) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Townsend AT; Featherstone AM; Peterson GM

2003Jacobson GA, Chong FV, Davies NW, 'LC-MS method for the determination of albuterol enantiomers in human plasma using manual solid-phase extraction and a non-deuterated internal standard', Journal of Pharmaceutical and Biomedical Analysis, 31, (6) pp. 1237-1243. ISSN 0731-7085 (2003) [Refereed Article]

DOI: 10.1016/S0731-7085(02)00734-3 [eCite] [Details]

Citations: Scopus - 26Web of Science - 23

Co-authors: Davies NW

Tweet

2003Jacobson GA, Chong FV, Wood-Baker R, '(R,S)-Salbutamol plasma concentrations in severe asthma', Journal of Clinical Pharmacy and Therapeutics, 28, (3) pp. 235-238. ISSN 0269-4727 (2003) [Refereed Article]

DOI: 10.1046/j.1365-2710.2003.00483.x [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Wood-Baker R

Tweet

2003Jacobson GA, McLean SR, 'Biological monitoring of low level occupational xylene exposure and the role of recent exposure', Annals of Occupational Hygiene, 47, (4) pp. 331-336. ISSN 0003-4878 (2003) [Refereed Article]

DOI: 10.1093/annhyg/meg045 [eCite] [Details]

Citations: Scopus - 13Web of Science - 10

Co-authors: McLean SR

Tweet

1998Jacobson GA, Blizzard CL, Dwyer T, 'Bicycle injuries: road trauma is not the only concern', Australian and New Zealand Journal of Public Health, 22, (4) pp. 451-455. ISSN 1326-0200 (1998) [Refereed Article]

DOI: 10.1111/j.1467-842X.1998.tb01413.x [eCite] [Details]

Citations: Scopus - 28Web of Science - 26

Co-authors: Blizzard CL; Dwyer T

Tweet

1997Jacobson GA, Peterson GM, McLean SR, 'Investigation of urinary levels of salbutamol in asthmatic patients receiving inhaled therapy', Journal of Clinical Pharmacy and Therapeutics, 22, (2) pp. 119-126. ISSN 0269-4727 (1997) [Refereed Article]

DOI: 10.1111/j.1365-2710.1997.tb00005.x [eCite] [Details]

Citations: Scopus - 8Web of Science - 9

Co-authors: Peterson GM; McLean SR

Tweet

1996Jacobson GA, Peterson GM, 'Prescribing trends for anti-asthma drugs in Tasmania following the National Asthma Campaign', Journal of Clinical Pharmacy and Therapeutics, 21, (5) pp. 317-324. ISSN 1365-2710 (1996) [Refereed Article]

DOI: 10.1111/j.1365-2710.1996.tb00025.x [eCite] [Details]

Citations: Web of Science - 4

Co-authors: Peterson GM

Tweet

1995Jacobson GA, Peterson GM, 'Stability of ipratropium bromide and salbutamol nebuliser admixtures', International Journal of Pharmacy Practice, 3, (3) pp. 169-173. ISSN 2042-7174 (1995) [Refereed Article]

DOI: 10.1111/j.2042-7174.1995.tb00812.x [eCite] [Details]

Co-authors: Peterson GM

Tweet

1994Jacobson GA, Peterson GM, 'High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution', Journal of Pharmaceutical and Biomedical Analysis, 12, (6) pp. 825-32. ISSN 0731-7085 (1994) [Refereed Article]

DOI: 10.1016/0731-7085(94)E0006-M [eCite] [Details]

Citations: Scopus - 44Web of Science - 32

Co-authors: Peterson GM

Tweet

1992Jacobson GA, Friesen WT, Peterson GM, Rumble RH, Polack AE, 'Psychoactive drug prescribing in the Tasmanian community', Medical Journal of Australia, 157, (1) pp. 20-4. ISSN 0025-729X (1992) [Refereed Article]

[eCite] [Details]

Citations: Scopus - 12Web of Science - 11

Co-authors: Friesen WT; Peterson GM; Rumble RH; Polack AE

Conference Publication

(37 outputs)
YearCitationAltmetrics
2016De Paoli AG, Wilson RR, Vervaart P, Dargaville PA, Jacobson GA, 'Identifying novel markers of late onset neonatal sepsis using proteomic analysis', Proceedings of the 20th Annual Congress of the Perinatal Society of Australia and New Zealand, May 22nd-25th, 2016, Townsville, Australia (2016) [Conference Extract]

[eCite] [Details]

Co-authors: De Paoli AG; Wilson RR; Dargaville PA

2016Raidal S, Jacobson GA, Robson K, Narkowicz CK, Nichols DS, et al., 'Enantioselective bronchopulmonary pharmacokinetics of salbutamol in horses', 2016 ACVIM Forum, 8-11 June, 2016, Denver, Colorado (2016) [Conference Extract]

[eCite] [Details]

Co-authors: Narkowicz CK; Nichols DS; Walters EH

2016Shafuddin E, Cooray M, Tuffery C, Hopping S, Sullivan G, et al., 'High-dose beta2-agonist treatment is associated with cardiac dysfunction in chronic obstructive pulmonary disease', Respirology, pp. 24. ISSN 1323-7799 (2016) [Conference Extract]

[eCite] [Details]

2015Jacobson GA, 'Investigation of salbutamol enantiomer deposition in epithelial lining fluid in horses', APSA-ASCEPT Joint Scientific Meeting 2015, 9 October, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

2015Hoyle D, Jacobson GA, Cui H, Rodemann T, 'Investigation of amyloid plaques and enoxaparin brain penetration using Raman and infrared spectroscopy', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Hoyle D; Cui H; Rodemann T

2014Pirie AD, Ahuja KDK, Jacobson GA, Geraghty DP, Narkowicz CK, et al., 'Glucose tolerance is improved by supplementation with carpobrotus rossii flavanoids in insulin resistant mice', Thirty-Eighth Annual Scientific Meeting of The Nutrition Society of Australia, 26 - 28 November, 2014, Hobart, Tasmania (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Pirie AD; Ahuja KDK; Geraghty DP; Narkowicz CK; Keske MA

2012Cui H, Hung AC, Narkowicz CK, Jacobson GA, Small DH, 'Effects of glycosaminoglycans on the level of β- and α-secretase and APP processing in Tg2576 primary cortical cells', Australian Neuroscience Society Annual Meeting, 29 January - 1 February, 2012, Gold Coast, Australia (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Cui H; Hung AC; Narkowicz CK; Small DH

2012Cui H, Hung AC, Freeman C, Narkowicz CK, Jacobson GA, et al., 'Effects of glycosaminoglycans on the level of β- and α-secretase and APP processing in Tg2576 primary cortical cells', APSN 2012, 29 September - 2 October, 2012, Kobe, Japan (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Cui H; Hung AC; Narkowicz CK; Small DH

2011Cui H, Hung AC, Klaver D, Narkowicz CK, Jacobson GA, et al., 'Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice', Australian Neuroscience Society 31st Annual Meeting, 31 January - 3 February, 2011, Auckland, New Zealand (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Cui H; Hung AC; Klaver D; Narkowicz CK; Small DH

2011Jin FM, Narkowicz CK, Bradbury RS, Bettiol SS, Mortia Y, et al., 'Ranunculin the antibacterial constituent in Clematis aristata, and its mode of action', Proceedings of APSA, 11 - 14 Dec, Adelaide (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Jin FM; Narkowicz CK; Bradbury RS; Bettiol SS

2010Geraghty DP, Jacobson GA, Narkowicz CK, Shing C, Pirie A, 'Effect of chronic Carpobrotus rossii (pigface) ingestion on systolic blood pressure, body weight, blood lipids, haematological profile and in vitro vascular function in adult male rats', Proceedings of ASCEPT, Dec 2010, Melbourne, pp. P36. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Geraghty DP; Narkowicz CK; Shing C; Pirie A

2009Adams MJ, Pinkard A, Geraghty DP, Jacobson GA, Jacobson GA, et al., 'Antiplatelet activity of Carpobrotus rossii (pigface) extract', Proceedings of ASCEPT, November, 2009, Sydney). O79., Sydney, pp. O79. (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Adams MJ; Pinkard A; Geraghty DP; Narkowicz CK; Ball MJ; Ahuja KDK

2009Geraghty DP, Jurkovic S, Vennavaram RR, Jager NGL, Jacobson GA, et al., 'Antioxidant activity of Carpobrotus rossii (pigface) extract', Proceedings of ASCEPT, November, 2009, Sydney). O79., Sydney, pp. O79. (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Geraghty DP; Jurkovic S; Jager NGL; Narkowicz CK; Ball MJ; Ahuja KDK

2009Jin FM, Narkowicz CK, Jacobson GA, 'Studies on the potential anticancer compounds of Tasmanian Clematis species', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 124. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Jin FM; Narkowicz CK

2009Liu T, Narkowicz CK, Jacobson GA, Hu X, 'Studies of chemical modification and formation of colon targeted microparticulates of Pachyman', Australasian Pharmaceutical Science Association Annual Conference Aus-CRS Symposium Program and Abstract book, 9-11 December 2009, Wrest Point Convention Centre, Hobart Tasmania, pp. 184. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Narkowicz CK

2009Patel RP, Narkowicz CK, Jacobson GA, 'A low-volume microtitre plate assay for determination of the AFXa activity of enoxaparin', Australasian Pharmaceutical Science Association Annual Conference Aus-CRS Symposium Program and Abstract book, 9-11 December 2009, Wrest Point Convention Centre, Hobart Tasmania, pp. 140. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Patel RP; Narkowicz CK

2009Thomas Jackson, Narkowicz CK, Jacobson GA, Davies NW, 'An examination of the essential oils of Tasmanian Kunzea ambigua, other Kunzea spp. and commercial kunzea oil', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 118. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Thomas Jackson; Narkowicz CK; Davies NW

2009Thomas Jackson, Narkowicz CK, Jacobson GA, Peterson GM, Basson S, 'An evaluation of the clinical efficacy of kunzea oil formulations in the therapeuticmanagement of psoriasis in adults', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre,Hobart, Tasmania , pp. 117. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM

2009Thomas Jackson, Narkowicz CK, Jacobson GA, Peterson GM, Burnet H, et al., 'A randomised trial of kunzea oil in comparison with amorolfine nail lacquer for the treatment of toenail onychomycosis', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, pp. 71. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM

2009Yee K, Jacobson GA, Wood-Baker R, Walters EH, 'Serum salbutamol enantiomer levels and extra pulmonary effects during disease exacerbation of COPD', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, pp. 68. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Yee K; Wood-Baker R; Walters EH

2009Yee K, Jacobson GA, Wood-Baker R, Walters EH, 'Genetic variations at activator protein-1 among patients with steroid-insensitive asthma', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 128. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Yee K; Wood-Baker R; Walters EH

2008Jacobson GA, 'Barrett's oesophagus: pilot application of MudPIT proteomics to oesophageal tissue after proton pump inhibitor therapy', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. ISBN 1111111111 (2008) [Conference Extract]

[eCite] [Details]

2008Narkowicz CK, Philip P, Jacobson GA, 'The chemistry and pharmaceutical potential of Callitris spp. from Tasmania', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Narkowicz CK

2008Narkowicz CK, Tieojaroenporn N, Jacobson GA, 'Saliva treatment of Dodoneae viscosa increases its antibacterial activity', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Narkowicz CK

2008Jin FM, Narkowicz CK, Jacobson GA, 'The screening of chemical constituents, antitumour and antimicrobial activities of Tasmanian clematis species', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Jin FM; Narkowicz CK

2007Jacobson GA, Ives S, Narkowicz CK, Jones G, 'Elevated plasma glutathione peroxidase concentration in rheumatoid arthritis', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Ives S; Narkowicz CK; Jones G

2007Jacobson GA, Yee K, Winburg M, 'Enantioselective distribution of (R/S)-salbutamol in skeletal muscle in a spinal muscular atrophy mouse model', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Yee K

2007Patel R, Narkowicz CK, Jacobson GA, 'The effect of heating on the chemistry and biological activity of enoxaparin', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Patel R; Narkowicz CK

2007Patel R, Narkowicz CK, Jacobson GA, 'The effects of freezing and thawing on the AFXa activity of enoxaparin solution', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Patel R; Narkowicz CK

2007Patel R, Narkowicz CK, Jacobson GA, 'Separation and characterisation of different low-molecular-weight heparins by reversed-phase ion-interaction high-performance liquid chromatography', Proceedings of the APSA Annual Conference, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Patel R; Narkowicz CK

2007Thomas J, Narkowicz CK, Jacobson GA, Peterson GM, Davies NW, 'Characterisation and evaluation of the in vitro antimicrobial activity of Kunzea ambigua essential oil', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Thomas J; Narkowicz CK; Peterson GM; Davies NW

2007Thomas Jackson, Narkowicz CK, Peterson GM, Jacobson GA, Narayana AK, 'Treatment of pastern dermatitis with a formulation containing kunzea oil' a randomised controlled trail', Annual Conference of Australasian Pharmaceutical Science Association Program and Abstract Book, 8-11 December 2007, Manly, NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Extract]

[eCite] [Details]

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM; Narayana AK

2007Vennavaram RR, Narkowicz CK, Jacobson GA, 'Chemical content and antioxidant activity of Carpobrotus rossii, C. edulis and C. aequilaterus', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Narkowicz CK

2007Webb C, Thomas Jackson, Narkowicz CK, Jacobson GA, Peterson GM, et al., 'Is the essential oil from the Australian native plant Kunzea ambigua repellent to mosquitoes?', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Thomas Jackson; Narkowicz CK; Peterson GM; Davies NW

2007Yee K, Jacobson GA, Wood-Baker R, Walters EH, 'Montelukast pharmacogenetics in a clinical setting as an adjunct therapy among patients using corticosteroids', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Yee K; Wood-Baker R; Walters EH

2007Yee K, Jacobson GA, Wood-Baker R, Walters EH, 'SULT1A3 Single Nucleotide Polymorphisms (SNPs) and their effect on Salbutamol Enantiomer Pharmacokinetics', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Yee K; Wood-Baker R; Walters EH

2004Townsend AT, Featherstone AM, Jacobson GA, Peterson GM, 'The Determination of Selenium in Human Plasma by Magnetic Sector ICP-MS', Abstract, 4-8 July 2004, Gold Coast, Queensland, Australia, pp. 209. (2004) [Conference Extract]

[eCite] [Details]

Co-authors: Townsend AT; Featherstone AM; Peterson GM

Patent

(1 outputs)
YearCitationAltmetrics
2003Peterson GM, Jacobson GA, 'A syringe guard' (2003) [Patent]

[eCite] [Details]

Co-authors: Peterson GM

Thesis

(1 outputs)
YearCitationAltmetrics
1996Jacobson GA, 'Aspects of the Pharmacotherapay of Airways Disease' (1996) [PhD]

[eCite] [Details]

Other Public Output

(21 outputs)
YearCitationAltmetrics
2015Jacobson GA, 'ABC Australia Wide Story on beta2-agonist doping control', Australia Wide November 21, ABC News, Online (2015) [Media Interview]

[eCite] [Details]

2015Jacobson GA, 'Tasmanian researchers scrutinise athletes' use of asthma treatment as performance enhancer', ABC News, Online (2015) [Media Interview]

[eCite] [Details]

2014Jacobson GA, 'Guest Blog: WADA turns to Tasmania in anti-doping efforts', SBS Cycling Central (2014) [Media Interview]

[eCite] [Details]

2014Jacobson GA, 'World Anti-Doping Agency's drug war comes to Tasmania', The Mercury, Online, August 12, 2014 (2014) [Newspaper Article]

[eCite] [Details]

1998Jacobson GA, 'TISPP Risk', RISK Bulletin, Tasmanian Injury Surveillance & Prevention Project, Tasmania, 44, June (1998) [Internal Newsletter]

[eCite] [Details]

1997Jacobson GA, 'Bike injuries', Bike injuries, Examiner, Tasmania, 15 Jan (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'T.I.S.P.P. RISK', RISK Bulletin, The Tasmanian Injury Surveillance and Prevention Program/Department of Community and Health Services, Tasmania, 42, May (1997) [Internal Newsletter]

[eCite] [Details]

1997Jacobson GA, 'T.I.S.P.P. RISK', RISK Bulletin, The Tasmanian Injury Surveillance and Prevention Program/Department of Community and Health Services, Tasmania, 43, October (1997) [Internal Newsletter]

[eCite] [Details]

1997Jacobson GA, 'Eye injuries', Eye injuries, Mercury, Tasmania, 30 May (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'Eye injuries', Eye injuries, Advocate, Tasmania, 4 Jun (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'Dangers of roller blading', Dangers of roller blading, Sunday Tasmanian, Tasmania, 13 Jul (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'Bike safety leaflet for young riders', Bike safety leaflet for young riders, The Star, Tasmania, 30 Oct (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'Netball most dangerous sport for females', The Mercury, Tasmania, 20/11/97 (1997) [Newspaper Article]

[eCite] [Details]

1997Jacobson GA, 'TISPP - eye injuries', TTT-FM News, Tasmania, 30/5/97 (1997) [Media Interview]

[eCite] [Details]

1997Jacobson GA, 'Bike Injuries', WIN TV News, Tasmania, 7/6/97 (1997) [Media Interview]

[eCite] [Details]

1996Jacobson GA, 'Most bike injuries 'off public roads'', The Examiner, Tasmania, January 15 (1996) [Newspaper Article]

[eCite] [Details]

1996Jacobson GA, 'Roads and guns most lethal risks', The Mercury, Tasmania, June 25 (1996) [Newspaper Article]

[eCite] [Details]

1996Jacobson GA, 'Tasmanian injury and prevention project', ABC Radio 7NT, Tasmania, 25 June (1996) [Media Interview]

[eCite] [Details]

1996Jacobson GA, 'Bike Injuries', Risk Bulletin, Tasmania, 40, Sept (1996) [Internal Newsletter]

[eCite] [Details]

1996Jacobson GA, 'Fatal Injuries in Tasmania from 1991 to 1994', Risk Bulletin, Tasmania, 39, June (1996) [Internal Newsletter]

[eCite] [Details]

1996Jacobson GA, 'Childhood Injuries', Risk Bulletin, Tasmania, 41, Dec (1996) [Internal Newsletter]

[eCite] [Details]

Grants & Funding

Dr Jacobson has been Chief Investigator on over 20 competitively funded grants securing over $1.3m of research funding during his career including ARC-LIEF and NHMRC, in addition to over $100k of industry funded research. Dr Jacobson has also been an associate investigator in the $4m NHMRC Centre for Research Excellence 'Breathe Well' related to his enantioselective beta2-agonist expertise. Dr Jacobson is internationally recognised for his work related to enantioselective beta2-agonist bioanalytical applications in the area of sports doping and has recently been the recipient of two international competitively funded World Anti-Doping Agency (WADA) research grants.

Funding Summary

Number of grants

37

Total funding

$1,656,086

Projects

Enantioselective pharmacokinetics of formoterol and application to doping control (2015 - 2016)$195,350
Description
The objectives of this project are to improve windows of detection of formoterol doping using enantioselective urine analyses.
Funding
World Anti-Doping Agency ($195,350)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Jacobson GA; Walters EH; Nichols DS
Period
2015 - 2016
Chemika impurity characterisation - ICH guidelines (2014)$8,794
Description
This project will identify degradation products that arise during routine quality control assays as part of compliance with ICH guidelines. Degradation products will be identified using a three step process of UPLC with low resolution MS and fractionation and purity testing, followed by high resolution MS (orbitrap), with subsequent NMR.
Funding
Chemika Pty ltd ($8,794)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA; Davies NW; Wilson RK; Horne HJ; Smith JA
Year
2014
Medication stability in the Pacific Islands (2014 - 2015)$16,364
Description
There are limited facilities in Pacific Island countries for pharmacovigilance and quality assurance services and most do not have any formal regulatory body (such as the Therapeutic Goods Administration in Australia) that approves medicines imported into the country. Quality is also confounded by cost and limited supply whereby drugs may need to be used beyond expiry date, as well as storage facilities and transport logistics in hot and humid environments; this can lead to medicines that may not be optimal when dispensed to patients. Even more concerning is the potential link between poor quality or ineffective medications and the emergence of resistance to antibiotics including anti-tuberculosis drugs. The project will undertake the chemical analysis of a range of common antibiotic drug batches at central storage facilities (including antibiotic tablets) using USP/BP testing with HPLC. These data will be used for research purposes; to assess the quality of medications in these nations building on previous research and provide data for the development of a drug storage and quality repository.
Funding
Dr Simon Quilty ($16,364)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Jacobson GA
Period
2014 - 2015
Enantioselective salbutamol analysis in blood of COPD patients (2014)$4,637
Description
Coexisting heart failure in patients with chronic obstructive pulmonary disease (COPD) is common, but often overlooked. Biomarkers of heart failure, such as brain natriuretic peptide (BNP) have been shown to predict mortality in COPD patients, although the mechanism behind this remains unclear. This study explores the mechanism that links cardiac dysfunction and COPD by studying the trends of cardiac biomarker levels in COPD patients and the correlation with clinical and cardiac functional assessments, and survival. This is a prospective study of COPD patients presenting with acute exacerbations, with no symptoms or signs suggesting acute coronary syndrome or acute pulmonary oedema. The project aims to recruit these participants when they are hospitalised and follow them up for 12 months. Participants will be reassessed during convalescence from these exacerbations (30-days from hospitalisation). Data including clinical, laboratory and cardiac functional findings will be collected during episode of acute exacerbation and during convalescence. Cardiac biomarkers will be measured on presentation, at 12 hours, at 72 hours (or on discharge, whichever is earlier) and during convalescence. The project will then investigate the trends of cardiac biomarkers correlated with the changes in clinical and cardiac functional assessments. The trends of cardiac biomarkers in patients with hypercapnic respiratory failure receiving non-invasive ventilation (NIV) will also be studied. Research will assess whether high levels of cardiac biomarkers at exacerbations correlate with serum beta-agonist levels. This will elucidate if the changes in cardiac biomarkers during acute exacerbation of COPD are associated with deterioration in cardiac function and the nature of this change in cardiac function (right or left ventricle). Simultaneous measurement of cardiac biomarkers and serum beta-agonist levels will address one of the potential explanations for the link between COPD exacerbations and cardiac dysfunction. The findings of this study may influence the treatment of cardiac disease in COPD patients.
Funding
Waikato Hospital ($4,637)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2014
Enantioselective pharmacokinetics of salbutamol and application to doping control (2014 - 2015)$139,880
Description
We will apply our advanced analytical technique that can measure both R- and S-salbutamol in urine, to samples from patients treated with either oral or inhaled therapy over the course of a week. The project will validate the benefits, namely increased sensitivity and reduced false positives and false negatives, of measuring R- and S-salbutamol enantiomers. This will allow to better discriminate between oral and inhaled salbutamol.
Funding
World Anti-Doping Agency ($139,880)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Jacobson GA; Walters EH
Period
2014 - 2015
Zebrafish: Pilot Applications in Muscle and Angiogenesis (2012)$5,000
Funding
University of Tasmania ($5,000)
Scheme
Grant-Research Enhancement (REGS)
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2012
Purchase of a new generation fast mapping Raman system (2011)$240,000
Description
The new fast imaging Raman system will be used to satisfy the research needs of a wide range of research projects within the chemical, health, pharmaceutical, material and earth sciences at UTAS. The facility is expected to substantially enhance the research outcomes of several internationally renowned researchers at UTAS.
Funding
Australian Research Council ($240,000)
Scheme
Grant-Linkage Infrastructure
Administered By
University of Tasmania
Research Team
Kamenetsky VS; Breadmore MC; Vickers JC; Jacobson GA; McGuinness DS
Year
2011
Grant Reference
LE110100041
Development of a Simple and Effective Ion-chromatagraphic Analysis for the Separation and Identification of Non-anticoagulant fractions of Enoxaparin (2011)$6,950
Funding
University of Tasmania ($6,950)
Scheme
Grant-Cross Theme
Administered By
University of Tasmania
Research Team
Patel RP; Hutchinson J; Johns CA; Jacobson GA; Narkowicz CK; Peterson GM
Year
2011
The Potential Role of Human Papilloma Virus in Short and Long Segment Barrett's Oesophagus and the Development of Dysplasia (2011 - 2012)$63,636
Funding
Clifford Craig Medical Research Trust ($63,636)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Rajendra S; Snow ET; Ball MJ; Robertson IK; Jacobson GA
Period
2011 - 2012
Investigations of the Chemical and Physical Stability of Iron Polymaltose Intravenous Infusion (2011)$6,364
Funding
Royal Hobart Hospital Research Foundation ($6,364)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Wanandy ST; Patel RP; Randall C; Jacobson GA; Holmes SE; Hutchinson C; Johns CA
Year
2011
Walter and Eliza Hall Fungal Screening Project (2010)$5,434
Funding
Walter and Eliza Hall Institute of Medical Research ($5,434)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Jacobson GA; Narkowicz CK
Year
2010
Purchase of an ultra-performance liquid chromatograph-triple quadrupole mass spectrometer (2010)$200,000
Funding
Australian Research Council ($200,000)
Scheme
Grant-Linkage Infrastructure
Administered By
University of Tasmania
Research Team
Davies NW; Reid JB; Canty AJ; Potts BM; Tamplin ML; Mohammed CL; Ross JJ; O'Reilly-Wapstra JM; Jacobson GA; Wright SW
Year
2010
Grant Reference
LE100100015
Identifying Novel Markers of Neonatal Sepsis (2010)$7,273
Funding
Royal Hobart Hospital Research Foundation ($7,273)
Scheme
Grant-Starter
Administered By
Royal Hobart Hospital Research Foundation
Research Team
De Paoli AG; Jacobson GA; Lee WL; Narkowicz CK; Vervaart P; Dargaville PA
Year
2010
Pilot Study of Gene Expression & Protein Regulation in Barrett's Oesophagus and Oesophageal Adenocarcinoma (2009)$8,761
Funding
Clifford Craig Medical Research Trust ($8,761)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Jacobson GA; Rajendra S; Snow ET; Ball MJ
Year
2009
Drug Discovery, Biotechnology and Bridging the Gap using an Intermediary: Pilot Application to Novel Flavonoids with Potential to Reduce Cardiovascular Disease Risk (2009)$19,799
Funding
University of Tasmania ($19,799)
Scheme
Grant-Cross Theme
Administered By
University of Tasmania
Research Team
Jacobson GA; Geraghty DP; Narkowicz CK; Hilder EF
Year
2009
Business Competition Grant - School of Pharmacy (2008)$25,000
Funding
University of Tasmania ($25,000)
Scheme
Grant-Business Competition
Administered By
University of Tasmania
Research Team
Jacobson GA; Narkowicz CK
Year
2008
R-Salbutamol dissolution from fish feed pellets (2007)$3,800
Funding
Stirling Products Limited ($3,800)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2007
Quantitative analysis of R-Salbutamol in feed samples (2007)$4,720
Funding
Stirling Products Limited ($4,720)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2007
Quantitative analysis of R-Salbutamol in pig muscle and liver: supplementation trial (2007)$6,480
Funding
Stirling Products Limited ($6,480)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2007
R, S-Salbutamol in chicken feed pellets (2007)$1,750
Funding
Stirling Products Limited ($1,750)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2007
Microsporum screening of algal extract formulation (2007)$1,700
Funding
Castella Research Pty Ltd ($1,700)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2007
Donation - Asthma Foundation of Tasmania PhD Scholarship for Kwang Choon Yee (2006 - 2009)$26,914
Funding
Donation via University of Tasmania Foundation ($26,914)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Jacobson GA
Period
2006 - 2009
Salbutamol Enantiomers in Delta-7 Mouse Plasma, Muscle and Brain- PK Range Study (2006)$3,360
Funding
Spinal Muscular Atrophy Foundation ($3,360)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2006
Hyphenated Capillary Electrophoresis-Mass Spectrometer Facility (2006)$262,706
Funding
Australian Research Council ($262,706)
Scheme
Grant-Linkage Infrastructure
Administered By
University of Tasmania
Research Team
Haddad PR; Clark MG; Reid JB; Bowie AR; Bowman JP; Ross JJ; Breadmore MC; McMeekin TA; Hilder EF; Guijt RM; Shellie RA; Jacobson GA
Year
2006
Grant Reference
LE0668471
Analysis of the Essential Oil of Kunzea Ambigua and Screening Formulation for Antibacterial and Antifungal Activities (2006 - 2008)$54,546
Funding
Armstrong Pharmacy ($54,546)
Scheme
Grant-Student Research
Administered By
University of Tasmania
Research Team
Jacobson GA; Narayana AK
Period
2006 - 2008
A Randomised Trial of Kunzea Oil in Comparison with Amorofline 5% Solution Nail Lacquer for the Treatment of Dermatophytic Toenail Onychomycoses (2006 - 2008)$88,875
Funding
Rural Industries Research & Development Corporation ($88,875)
Scheme
Grant-Research Priorities Program
Administered By
University of Tasmania
Research Team
Jacobson GA; Peterson GM
Period
2006 - 2008
Deslorelin implant analysis: effect of e-beam sterilisation (2005)$4,440
Funding
Castella Research Pty Ltd ($4,440)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2005
Deslorelin implant analysis: used implants #2 (2005)$3,320
Funding
Castella Research Pty Ltd ($3,320)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2005
Ceftiofur analysis in bovine serum (2004)$11,730
Funding
Castella Research Pty Ltd ($11,730)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2004
Deslorelin in plasma by LC-MS: methos development (2004)$5,000
Funding
Castella Research Pty Ltd ($5,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2004
Pharmacoproteomic Investigation of Barrett's Oesophagus and Proton Pump Inhibitor Therapy (2004)$6,364
Funding
Royal Hobart Hospital Research Foundation ($6,364)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Jacobson GA; Lord RJ; Chung S
Year
2004
Tasmania: A Selenium-deficient State? A Population-based Assessment of Selenium Status (2003)$17,273
Funding
Royal Hobart Hospital Research Foundation ($17,273)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Peterson GM; Jacobson GA; Ball MJ; Vial JH
Year
2003
Stereoselective Metabolism of Salbutamol as a Determinant of the Response in Acute Asthma (2002)$4,000
Funding
Royal Hobart Hospital Research Foundation ($4,000)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2002
Cancer Prevention in Barrett's Oesophagus: Celecoxib and In Vivo Assessment of COX-2 Expression in Metaplastic and Dysplastic Oesophageal Epithelium (2002)$7,824
Funding
Royal Hobart Hospital Research Foundation ($7,824)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Jacobson GA
Year
2002
Tasmania: a selenium-deficient state? (2002)$16,000
Funding
University of Tasmania ($16,000)
Scheme
Grant-Institutional Research Scheme
Administered By
University of Tasmania
Research Team
Peterson GM; Jacobson GA; Townsend AT; Ball MJ; Vial JH; Davies NW
Year
2002
Risk Factors for Upper Limb Fractures in Adolescence (1999 - 2000)$165,040
Funding
National Health & Medical Research Council ($165,040)
Scheme
Grant-MRC Project
Administered By
University of Tasmania
Research Team
Jones G; Morley R; Jacobson GA
Period
1999 - 2000
Grant Reference
990042
Risk Factors for Upper Limb Fractures in Adolescence (1998)$7,002
Funding
Clifford Craig Medical Research Trust/UTAS ($7,002)
Scheme
Grant-Collaborative
Administered By
University of Tasmania
Research Team
Jones G; Morley R; Jacobson GA
Year
1998

Research Supervision

Dr Jacobson has supervised 8 RHD graduands, and is currently supervising 4 RHD students. Opportunities for PhD supervision and scholarships may arise in the area of beta2-agonists/muscle related projects for students with demonstrated excellence in sports science, muscle and cardiorespiratory physiology or drug testing background.

Current

3

Completed

10

Current

DegreeTitleCommenced
PhDThe Safety and Efficacy of Electronic-Cigarettes as Cessation Aids and the use of Electronic-Cigarettes by Smokers2013
PhDThe Role of Mitochondria in the Visual Function of Zebrafish (Danio. rerio)2013
PhDThe microvascular effects of novel flavonoid compounds on enhancing the action of anti-diabetic drugs2014

Completed

DegreeTitleCompleted
PhDApplication of Infra-Red Spectroscopy to the Evaluation of Biofilm Formation and Pathogenesis of Nontypeable Haemophilus influenzae
Candidate: Najla Abdullah Obaid
2016
PhDThe Pharmaceutical and Nutraceutical Potential of the Halophytic Plant Carpobrotus rossii
Candidate: Adam Douglas Pirie
2014
PhDFactors Influencing the Performance and Documentation of Clinical Interventions by Australian Community Pharmacists
Candidate: Mackenzie Williams
2013
PhDStudies on the Use of Glycosaminoglycans for the Treatment of Alzheimer's Disease
Candidate: Hao Cui
2012
PhDThe Pharmaceutical Potential of Compounds from Tasmanian Clematis Species
Candidate: Fangming Jin
2012
PhDKunzea Oil: Investigation of Composition, Bioactivity and Therapeutic Potential
Candidate: Jackson Thomas
2010
PhDPharmacogenetics and Chiral Aspects of Anti-Asthma Therapy
Candidate: Kwang Choon Yee
2009
MastersExtraction, Analysis, and Biological Screening of Callitris Species Essential Oils
Candidate: Prince Ninan Philip
2009
PhDEnoxaparin: Physicochemical Investigations into the Effects of Freezing and Heating
Candidate: Rahul Prabhudas Patel
2008
MastersInvestigation of Chemical Components and Pharmaceutical Potential of Carpobrotus Species
Candidate: Raghunath Reddy Vennavaram
2007